NCT05037240View on ClinicalTrials.gov

Quercetin in the Prevention of Covid-19 Infection

NACompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

January 12, 2021

Primary Completion Date

April 6, 2021

Study Completion Date

May 25, 2021

Conditions
Covid19
Interventions
DIETARY_SUPPLEMENT

Quercetin

Quercetin (500 mg), 2 times a day for 3 months

COMBINATION_PRODUCT

Placebo

500 mg, 2 times a day for 3 months

Trial Locations (1)

27100

Mariangela Rondanelli, Pavia

All Listed Sponsors
lead

Azienda di Servizi alla Persona di Pavia

OTHER

NCT05037240 - Quercetin in the Prevention of Covid-19 Infection | Biotech Hunter | Biotech Hunter